Literature DB >> 20072052

Direct validity of the yo-yo intermittent recovery test in young team handball players.

Hermassi Souhail1, Carlo Castagna, Haj Yahmed Mohamed, Hachana Younes, Karim Chamari.   

Abstract

The aim of this study was to examine the possible association between Yo-Yo intermittent recovery test level 1 performance (distance covered, Yo-Yo IR1) and match activities (direct validity) in young male team handball players. Eighteen young male players (age 14.3 +/- 0.5 years, body mass 64 +/- 28.7 kg, height 174 +/- 6 cm, body fat 11.2 +/- 3.9%) took part in this study. Players' match activities were videotaped during an experimental tournament (6 games/player) and analyzed using a computerized system. Games and Yo-Yo IR1 heart rates (HRs) (short-range telemetry, HR) and blood lactate concentrations ([la]b) were assessed throughout and at selected times of the games, respectively. Peak Yo-Yo IR1 HR was assumed as representative of individual maximal HR (HRmax). Mean and peak game HRs were 174 +/- 3 and 198 +/- 2 b.min, which corresponded to 87 and 99% of HRmax, respectively. Yo-Yo IR1 performance (1,831 +/- 373 m) was significantly related (r = 0.88, p < 0.01) to total game distance (1,921 +/- 325 m). Post-game (9.2 +/- 2.3 mmol.L) and Yo-Yo IR1 (8.8 +/- 1.6 mmol.L) [la]b were significantly related (r = 0.51, p < 0.05). These findings demonstrated the direct validity of Yo-Yo IR1. Consequently, Yo-Yo IR1 test may be considered as a team handball test relevant for the assessment of intermittent high-intensity endurance in young male team handball players.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072052     DOI: 10.1519/JSC.0b013e3181c06827

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  8 in total

Review 1.  On-court demands of elite handball, with special reference to playing positions.

Authors:  Claude Karcher; Martin Buchheit
Journal:  Sports Med       Date:  2014-06       Impact factor: 11.136

2.  The Yo-Yo intermittent recovery test level 1 is reliable in young high-level soccer players.

Authors:  D Deprez; J Fransen; M Lenoir; Rm Philippaerts; R Vaeyens
Journal:  Biol Sport       Date:  2014-11-03       Impact factor: 2.806

3.  Relationships between the yo-yo intermittent recovery test and anaerobic performance tests in adolescent handball players.

Authors:  Souhail Hermassi; Ridha Aouadi; Riadh Khalifa; Roland van den Tillaar; Roy J Shephard; Mohamed Souhaiel Chelly
Journal:  J Hum Kinet       Date:  2015-04-07       Impact factor: 2.193

4.  Multi Directional Repeated Sprint Is a Valid and Reliable Test for Assessment of Junior Handball Players.

Authors:  Amin Daneshfar; Daniel E Gahreman; Majid S Koozehchian; Sadegh Amani Shalamzari; Mozhgan Hassanzadeh Sablouei; Thomas Rosemann; Beat Knechtle; Pantelis T Nikolaidis
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

5.  Effects of small-sided games vs. simulated match training on physical performance of youth female handball players.

Authors:  Rasa Mikalonytė; Rūtenis Paulauskas; Eduardo Abade; Bruno Figueira
Journal:  PLoS One       Date:  2022-09-13       Impact factor: 3.752

6.  Exercise Intensity and Technical Involvement in U9 Team Handball: Effect of Game Format.

Authors:  Georgios Ermidis; Rasmus C Ellegard; Vincenzo Rago; Morten B Randers; Peter Krustrup; Malte N Larsen
Journal:  Int J Environ Res Public Health       Date:  2021-05-25       Impact factor: 3.390

7.  Study of Physical Fitness, Bone Quality, and Mediterranean Diet Adherence in Professional Female Beach Handball Players: Cross-Sectional Study.

Authors:  Alejandro Martínez-Rodríguez; Javier Sánchez-Sánchez; María Martínez-Olcina; Manuel Vicente-Martínez; Laura Miralles-Amorós; Juan Antonio Sánchez-Sáez
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

8.  Repeated sprint training in normobaric hypoxia.

Authors:  Harvey M Galvin; Karl Cooke; David P Sumners; Katya N Mileva; Joanna L Bowtell
Journal:  Br J Sports Med       Date:  2013-12       Impact factor: 13.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.